Asymmetric Synthesis of Functionalized
Diarylmethanols Catalyzed by a New γ-Amino
Thiol
Ping-Yu Wu, Hsyueh-Liang Wu, and Biing-Jiun Uang*
Department of Chemistry, National Tsing Hua UniVersity,
Hsinchu, 300 Taiwan
ReceiVed September 27, 2005
FIGURE 1. Biologically active diarylmathanol derivatives and CDP-
840.
by nucleophilic displacement5 at the hydroxyl-bearing stereo-
genic center in optically active diarylmethanols.
Among the methods available for the synthesis of chiral
diarylmethanols,6 the asymmetric addition of diphenylzinc7-9
(5) (a) Hillier, M. C.; Desrosiers, J.-N.; Marcoux, J.-F.; Grabowski, E.
J. J. Org. Lett. 2004, 6, 573-576. (b) O’Shea, P. D.; Chen, C.-Y.; Chen,
W. R.; Dagneau, P.; Frey, L. F.; Grabowski, E. J. J.; Marcantonio, K. M.;
Reamer, R. A.; Tan, L.; Tillyer, R. D.; Roy, A.; Wang, X.; Zhao, D. L. J.
Org. Chem. 2005, 70, 3021-3030. (c) Bolshan, Y.; Chen, C.-Y.; Chilenski,
J. R.; Gosselin, F.; Mathre, D. J.; O’Shea, P. D.; Roy, A.; Tillyer, R. D.
Org. Lett. 2004, 6, 111-114.
(6) For reviews of asymmetric arylation reactions, see: (a) Bolm, C.;
Hildebrand, J. P.; Mun˜iz, K.; Hermanns, N. Angew. Chem., Int. Ed. 2001,
40, 3284-3308. (b) Noyori, R.; Ohkuma, T. Angew. Chem., Int. Ed. 2001,
40, 40-73. (c) Corey, E. J.; Helal, C. J. Angew. Chem., Int. Ed. 1998, 37,
1986-2012.
(7) For examples, see: (a) O¨ zc¸ubukc¸u, S.; Schmidt, F.; Bolm, C. Org.
Lett. 2005, 7, 1407-1409. (b) Bolm, C.; Kesselgruber, M.; Hermanns, N.;
Hildebrand, J. P.; Raabe, G. Angew. Chem., Int. Ed. 2001, 40, 1488-1490.
(c) Bolm, C.; Hermanns, N.; Hildebrand, J. P.; Mun˜iz, K. Angew. Chem.,
Int. Ed. 2000, 39, 3465-3467. (d) Bolm, C.; Mun˜iz, K. Chem. Commun.
1999, 1295-1296. (e) Huang, W.-S.; Pu, L. Tetrahedron Lett. 2000, 41,
145. (f) Huang, W.-S.; Hu, Q.-S.; Pu, L. J. Org. Chem. 1999, 64, 7940-
7956. (g) Huang, W.-S.; Pu, L. J. Org. Chem. 1999, 64, 4222-4223. (h)
Fontes, M.; Verdaguer, X.; Sola`, L.; Perica`s, M. A.; Riera, A. J. Org. Chem.
2004, 69, 2532-2543. (i) Ko, D.-K.; Kim, K.-H.; Ha, D.-C. Org. Lett. 2002,
4, 3759-3762. (j) Zhao, G.; Li, X.-G.; Wang, X.-R. Tetrahedron:
Asymmetry 2001, 12, 399-403. (k) Dosa, P. I.; Ruble, J. C.; Fu, G. C. J.
Org. Chem. 1997, 62, 444-445.
A mild asymmetric arylation of aromatic aldehydes catalyzed
by γ-amino thiol 5 gave the corresponding diarylmethanols
with 95 to >99.5% ee.
Chiral diarylmethanols play an important role in the synthesis
of biologically active compounds,1 such as orphenadrine (1),
neobenodine (2),1d carbinoxamine (3)1e (Figure 1) and others2
which possess a common core feature in novel drug design. In
addition to their direct applications, chiral diarylmethanols could
also serve as useful intermediates in the synthesis of drugs. For
example, CDP-840 (4) (Figure 1)3 and its analogues are PDE-
IV inhibitors that are potent therapeutic agents for the treatment
of asthma and chronic obstructive pulmonary disease.4 Prepara-
tion of optically active trisubstituted diarylmethanes in this
analogues can be achieved without any loss of optical purity
* To whom correspondence should be addressed. Fax: 886-3-5711082. Tel:
886-3-5721224.
(1) (a) Meguro, K.; Aizawa, M.; Sohda, T.; Kawamatsu, Y.; Nagaoka,
A. Chem. Pharm. Bull. 1985, 33, 3787-3797. (b) Toda, F.; Tanaka, K.;
Koshiro, K. Tetrahedron: Asymmetry 1991, 2, 873-874. (c) Stanchev, S.;
Rakovska, R.; Berova, N.; Snatzke, G. Tetrahedron: Asymmetry 1995, 6,
183-198. (d) Casy, A. F.; Drake, A. F.; Ganellin, C. R.; Mercer, A. D.;
Upton, C. Chirality 1992, 4, 356-366. (e) Shafi’ee, A.; Hite, G. J. Med.
Chem. 1969, 12, 266-270.
(2) For an example, see: McCalmont, W. F.; Heady, T. N.; Patterson,
J. R.; Lindenmuth, M. A.; Haverstick, D. M.; Gray, L. S.; Macdonald, T.
L. Bioorg. Med. Chem. Lett. 2004, 14, 3691-3695.
(3) Boyd, E. C.; Eaton, M. A. W.; Warrellow, G. J. World Patent WO
94/10118, 1994.
(4) (a) Alexander, R. P.; Warrellow, G. J.; Eaton, M. A. W.; Boyd, E.
C.; Head, J. C.; Porter, J. R.; Brown, J. A.; Reuberson, J. T.; Hutchinson,
B.; Turner, P.; Boyce, B.; Barnes, D.; Mason, B.; Cannell, A.; Taylor, R.
J.; Zomaya, A.; Millican, A.; Leonard, J.; Morphy, R.; Wales, M.; Perry,
M.; Allen, R. A.; Gozzard, N.; Hughes, B.; Higgs, G. Bioorg. Med. Chem.
Lett. 2002, 12, 1451-1456. (b) Guay, D.; Hamel, P.; Blouin, M.; Brideau,
C.; Chan, C. C.; Chauret, N.; Ducharme, Y.; Huang, Z.; Girard, M.; Jones,
T. R.; Laliberte, F.; Masson, P.; McAuliffe, M.; Piechuta, H.; Silva, J.;
Young, R. N.; Girard, Y. Bioorg. Med. Chem. Lett. 2002, 12, 1457-1461.
(8) For some theoretical studies on diphenylzinc addition reactions, see:
(a) Rudolph, J.; Bolm, C.; Norrby, P.-O. J. Am. Chem. Soc. 2005, 127,
1548-1552. (b) Rudolph, J.; Rasmussen, T.; Bolm, C.; Norrby, P.-O.
Angew. Chem., Int. Ed. 2003, 42, 3002-3005.
(9) For recent studies of other organozinc reagents, see: (a) Jeon, S.-J.;
Chen, Y.-K.; Walsh, P. J. Org. Lett. 2005, 7, 1729-1732. (b) Lurain, A.
E.; Carroll, P. J.; Walsh, P. J. J. Org. Chem. 2005, 70, 1262-1268. (c)
Lurain, A. E.; Walsh, P. J. J. Am. Chem. Soc. 2003, 125, 10677-10683.
(d) Lurain, A. E.; Maestri, A.; Kelly, A. R.; Carroll, P. J.; Walsh, P. J. J.
Am. Chem. Soc. 2004, 126, 13608-13609. (e) Chen, Y. K.; Lurain, A. E.;
Walsh, P. J. J. Am. Chem. Soc. 2002, 124, 12225-12231. (f) Ji, J.-X.; Qiu,
L.-Q.; Yip, C. W.; Chan, A. S. C. J. Org. Chem. 2003, 68, 1589-1590. (g)
Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2003, 125,
761-768. (h) Wipf, P.; Kendall, C. Chem. Eur. J. 2002, 8, 1778-1784. (i)
Oppolzer, W.; Radinov, R. N. HelV. Chim. Acta 1992, 75, 170-173. (j)
Oppolzer, W.; Radinov, R. N.; El-Sayed, E. J. Org. Chem. 2001, 66, 4766-
4770. (k) Tseng, S.-L.; Yang, T.-K. Tetrahedron: Asymmetry 2005, 16,
773-782. (l) Bra¨se, S.; Dahmen, S.; Ho¨fener, S.; Lauterwasser, F.; Kreis,
M.; Ziegert, R. E. Synlett 2004, 2647-2669. (m) Dahmen, S.; Bra¨se, S.
Org. Lett. 2001, 3, 4119-4122.
10.1021/jo052017b CCC: $33.50 © 2006 American Chemical Society
Published on Web 12/06/2005
J. Org. Chem. 2006, 71, 833-835
833